KA
Kintegral Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.79M | Sell |
125,135
-188
| -0.2% | -$8.7K | 0.53% | 52 |
|
2025
Q1 | $7.64M | Sell |
125,323
-422
| -0.3% | -$25.7K | 0.77% | 29 |
|
2024
Q4 | $7.11M | Sell |
125,745
-5,858
| -4% | -$331K | 0.67% | 35 |
|
2024
Q3 | $6.81M | Sell |
131,603
-1,724
| -1% | -$89.2K | 0.62% | 40 |
|
2024
Q2 | $5.54M | Buy |
133,327
+55,204
| +71% | +$2.29M | 0.53% | 48 |
|
2024
Q1 | $4.24M | Sell |
78,123
-244
| -0.3% | -$13.2K | 0.42% | 67 |
|
2023
Q4 | $4.02M | Sell |
78,367
-499
| -0.6% | -$25.6K | 0.45% | 59 |
|
2023
Q3 | $4.58M | Sell |
78,866
-47
| -0.1% | -$2.73K | 0.57% | 45 |
|
2023
Q2 | $5.05M | Hold |
78,913
| – | – | 0.6% | 41 |
|
2023
Q1 | $5.47M | Sell |
78,913
-4,240
| -5% | -$294K | 0.71% | 37 |
|
2022
Q4 | $5.98M | Buy |
83,153
+17,254
| +26% | +$1.24M | 0.79% | 33 |
|
2022
Q3 | $4.69M | Hold |
65,899
| – | – | 0.65% | 32 |
|
2022
Q2 | $5.11M | Buy |
65,899
+1,395
| +2% | +$108K | 0.66% | 33 |
|
2022
Q1 | $4.75M | Buy |
64,504
+1,443
| +2% | +$106K | 0.52% | 42 |
|
2021
Q4 | $3.93M | Hold |
63,061
| – | – | 0.41% | 57 |
|
2021
Q3 | $3.76M | Hold |
63,061
| – | – | 0.44% | 58 |
|
2021
Q2 | $4.21M | Hold |
63,061
| – | – | 0.5% | 52 |
|
2021
Q1 | $4.01M | Hold |
63,061
| – | – | 0.52% | 48 |
|
2020
Q4 | $3.94M | Hold |
63,061
| – | – | 0.54% | 46 |
|
2020
Q3 | $3.8M | Sell |
63,061
-2,030
| -3% | -$122K | 0.58% | 42 |
|
2020
Q2 | $3.83M | Hold |
65,091
| – | – | 0.62% | 38 |
|
2020
Q1 | $3.63M | Buy |
65,091
+7,284
| +13% | +$406K | 0.71% | 35 |
|
2019
Q4 | $3.71M | Buy |
57,807
+17,299
| +43% | +$1.11M | 0.67% | 36 |
|
2019
Q3 | $2.05M | Hold |
40,508
| – | – | 0.41% | 73 |
|
2019
Q2 | $1.84M | Hold |
40,508
| – | – | 0.37% | 79 |
|
2019
Q1 | $1.93M | Buy |
40,508
+20,814
| +106% | +$993K | 0.41% | 72 |
|
2018
Q4 | $1.02M | Buy |
+19,694
| New | +$1.02M | 0.3% | 83 |
|